PUBLISHER: IMARC | PRODUCT CODE: 1541802
PUBLISHER: IMARC | PRODUCT CODE: 1541802
Immunomodulators Market Report by Product (Immunosuppressants, Immunostimulants), Application (Oncology, Respiratory, HIV, and Others), and Region 2024-2032
The global immunomodulators market size reached US$ 211.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 331.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032.
Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).
Immunomodulators Market Trends:
The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global immunomodulators market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and application.
Breakup by Product:
Immunosuppressants
Antibodies
Calcineurin Inhibitors
Glucocorticoids
Antimetabolites
Others
Immunostimulants
Vaccines
Antibodies
Others
Breakup by Application:
Oncology
Respiratory
HIV
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.
Key Questions Answered in This Report:
- How has the global immunomodulators market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global immunomodulators market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global immunomodulators market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Immunomodulators Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Immunosuppressants
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Antibodies
- 6.1.2.2 Calcineurin Inhibitors
- 6.1.2.3 Glucocorticoids
- 6.1.2.4 Antimetabolites
- 6.1.2.5 Others
- 6.1.3 Market Forecast
- 6.2 Immunostimulants
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Vaccines
- 6.2.2.2 Antibodies
- 6.2.2.3 Others
- 6.2.3 Market Forecast
7 Market Breakup by Application
- 7.1 Oncology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Respiratory
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 HIV
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Amgen Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Biogen Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Bristol-Myers Squibb Company
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Eli Lilly and Company
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 F. Hoffmann-La Roche AG
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 SWOT Analysis
- 13.3.6 Johnson & Johnson
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Merck & Co. Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Novartis AG
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Pfizer Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.1 Amgen Inc.
List of Figures
- Figure 1: Global: Immunomodulators Market: Major Drivers and Challenges
- Figure 2: Global: Immunomodulators Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Immunomodulators Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Immunomodulators Market: Breakup by Product (in %), 2023
- Figure 5: Global: Immunomodulators Market: Breakup by Application (in %), 2023
- Figure 6: Global: Immunomodulators Market: Breakup by Region (in %), 2023
- Figure 7: Global: Immunomodulators (Immunosuppressants) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 8: Global: Immunomodulators (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 9: Global: Immunomodulators (Immunostimulants) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Immunomodulators (Immunostimulants) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Immunomodulators (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Immunomodulators (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Immunomodulators (Respiratory) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Immunomodulators (Respiratory) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Immunomodulators (HIV) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Immunomodulators (HIV) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Immunomodulators (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Immunomodulators (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: North America: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: North America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: United States: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: United States: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Canada: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Canada: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Asia-Pacific: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Asia-Pacific: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: China: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: China: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Japan: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Japan: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: India: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: India: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: South Korea: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: South Korea: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Australia: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Australia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Indonesia: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Indonesia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Others: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Europe: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Europe: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Germany: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Germany: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: France: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: France: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: United Kingdom: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: United Kingdom: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Italy: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Italy: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Spain: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Spain: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Russia: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Russia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Others: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Latin America: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Latin America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Brazil: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Brazil: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Mexico: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Mexico: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Others: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Middle East and Africa: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Middle East and Africa: Immunomodulators Market: Breakup by Country (in %), 2023
- Figure 67: Middle East and Africa: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Global: Immunomodulators Industry: SWOT Analysis
- Figure 69: Global: Immunomodulators Industry: Value Chain Analysis
- Figure 70: Global: Immunomodulators Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Immunomodulators Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Immunomodulators Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: Immunomodulators Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 4: Global: Immunomodulators Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 5: Global: Immunomodulators Market: Competitive Structure
- Table 6: Global: Immunomodulators Market: Key Players
